Cited by 1,143Epigenetics and DNA MethylationCancer Cells and MetastasisPluripotent Stem Cells Research

Epigenetic stem cell signature in cancer

Widschwendter, Martin, Fiegl, Heidi, Egle, Daniel, Mueller-Holzner, Elisabeth, Spizzo, Gilbert, Marth, Christian, Weisenberger, Daniel J, Campan, Mihaela +3 more·2007·Nature Genetics

Abstract

Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have cancer-specific promoter DNA hypermethylation than non-targets, supporting a stem cell origin of cancer in which reversible gene repression is replaced by permanent silencing, locking the cell into a perpetual state of self-renewal and thereby predisposing to subsequent malignant transformation.

Integrity signals

Registry

Crossref · 10.1038/ng1941

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., & Laird, P. W.
Affiliations
  • University College London (GB)
  • Innsbruck Medical University (AT)
  • USC Norris Comprehensive Cancer Center (US)
  • QIMR Berghofer Medical Research Institute (AU)
Corresponding author
  • Widschwendter, Martin
  • Laird, Peter W
Venue
Nature Genetics
Published
2006-12-31
Volume
39
Issue
2
Pages
157-158
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2042087070
Cited by
1,143
References
15
Citations by year
2026: 11 · 2025: 18 · 2024: 30 · 2023: 42 · 2022: 34 · 2021: 45 · 2020: 45 · 2019: 32 · 2018: 36 · 2017: 47 · 2016: 55 · 2015: 64 · 2014: 68 · 2013: 90 · 2012: 95
FWCI
33.42
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • European Commission
  • National Institutes of Health (5r01ca075090-09)
  • National Cancer Institute (R01-CA-075090, R01CA001815, R01CA096958)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
Polycomb group proteins, DNA methylation, promoter hypermethylation, cancer stem cells, embryonic stem cells, gene repression, self-renewal, malignant transformation, epigenetics, cancer susceptibility
MeSH terms
Cell Differentiation, Cell Transformation, Neoplastic, Humans, Neoplasms, Repressor Proteins, Stem Cells, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Polycomb-Group Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review